Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis

Dafni, U.Soo, R. A.Peters, S.Tsourti, Z.Vervita, K.Han, J-Y.De Castro, J.Coate, L.Frueh, M.Hashemi, S. M. S.Nadal, E.Carcereny, E.Sala Gonzalez, M. AngelesBernabe Caro, R.Provencio Pulla, M.Cuffe, S.Ruepp, B.Roschitzki-Voser, H.Rosell, R.Stahel, R. A.2023-05-032023-05-032022-04-020923-7534http://hdl.handle.net/10668/21889enImpact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysisconference outputopen access10.1016/j.annonc.2022.02.0411569-8041http://www.annalsofoncology.org/article/S0923753422001570/pdf778453100033